| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand Name | TAK-475 | |
| 3 | Generic Name | lapaquistat | |
| 4 | Timeline | DISCONTINUED 3/28/2008 | |
| 5 | Mechanism | Squalene Synthase inhibitor | |
| 6 | Commenatry | "Lipid lowering fairly modest". | |
| 7 | Safety | Liver enzyme elevations? | |
| 8 | Clinical Data | ||
| 9 | Phase 2 comparable to Zetia |